<HTML>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2018 [PPXK5GW761L0VLXL4WK7]. www.edgarsuite.com -->
<HEAD>
</HEAD>
<BODY>
<DIV style=margin-left:72pt;width:468pt><P align=center style='font:10pt Times New Roman;margin:0'>UNITED STATES<BR>SECURITIES AND EXCHANGE COMMISSION<BR>Washington, D.C. 20549</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>FORM 8-K</B></P>
<P align=center style='font:10pt Times New Roman;margin-top:24pt;margin-bottom:0pt;color:#000000'><B>CURRENT REPORT</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>Date of Report (Date of earliest event reported): May 2, 2019</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>NEWBRIDGE GLOBAL VENTURES, INC.</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(Exact Name of Registrant as Specified in its Charter)</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
<TABLE align=center style=border-collapse:collapse><TR><TD valign=top style=width:170.95pt;padding:0.75pt><P align=center style='font:10pt Times New Roman;margin:0'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<B>Delaware&#160;&#160;&#160;&#160;&#160;&#160;&#160;</B></P>
</TD><TD valign=top style=width:126.05pt;padding:0.75pt><P align=center style='font:10pt Times New Roman;margin:0'><B>0-11730</B></P>
</TD><TD valign=top style=width:139.5pt;padding:0.75pt><P align=center style='font:10pt Times New Roman;margin:0'><B>84-1089377</B></P>
</TD></TR>
<TR><TD valign=top style=width:170.95pt;padding:0.75pt><P align=center style='font:10pt Times New Roman;margin:0'>(State or other jurisdiction<BR>of incorporation)</P>
</TD><TD valign=top style=width:126.05pt;padding:0.75pt><P align=center style='font:10pt Times New Roman;margin:0'>Commission File<BR>Number</P>
</TD><TD valign=top style=width:139.5pt;padding:0.75pt><P align=center style='font:10pt Times New Roman;margin:0'>(I.R.S. Employer Identification number)</P>
</TD></TR>
</TABLE>
<P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><B>2545 Santa Clara Avenue</B></P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><B>Alameda, CA 94501</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Address of Principal Executive Offices)&#160;&#160;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>801-362-2115</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(Registrant&#8217;s Telephone Number, Including Area Code)</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P style='font:10pt Times New Roman;margin:0'>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>
<P style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-family:Wingdings>&#111;</FONT>&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>
<P style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-family:Wingdings>&#111;</FONT>&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>
<P style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-family:Wingdings>&#111;</FONT>&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>
<P style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-family:Wingdings>&#111;</FONT>&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>
<P style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:10pt;margin-left:72pt;color:#000000'>&#160;</P>
<P style='font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'><B>Item 1.01 Entry into a Material Definitive Agreement</B></P>
<P style='font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'>On May 2, 2019, NewBridge Global Ventures, Inc., a Delaware Corporation (the &#8220;Company&#8221;) and Apothio, LLC, a Colorado limited liability company (&#8220;Apothio&#8221;) entered into an Operating Agreement (the &#8220;Operating Agreement&#8221;), pursuant to which the Company and Apothio agreed to form Apothio Bakersefield, LLC, a Nevada limited liability company (the &#8220;Joint Venture&#8221;), whereby pursuant to the terms and subject to the conditions set forth in the Operating Agreement, the Company and Apothio shall each receive fifty percent (50%) of the membership interests in the Joint Venture. Under the terms of the Operating Agreement, the Company will be required to: (i) underwrite costs to contribute extraction equipment; (ii) fund the cost of a fully-functional extraction facility and (iii) install a fully-functional testing laboratory with certain equipment as determined by the managers of the Joint Venture. Apothio will contribute existing biomass of approximately 150,000 pounds for the Company to begin processing and extraction, and will contribute the use of its 512 acres of cannabinoids plants. The term of the Operating Agreement shall be perpetual absent certain dissolution provisions as further described in the Operating Agreement. </P>
<HR style='page-break-after:always;border:0;height:3.75pt;background-color:#919191;margin:15pt 0'><P style=line-height:0;margin:0></P>
<P style='font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'>The Operating Agreement also provides for certain drag-along provisions, whereby the managers may require any members of the Joint Venture to sell their respective membership interests to a proposed purchaser. </P>
<P style='font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'>&#160;</P>
<P style='font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'>The foregoing is merely a summary of the Operating Agreement, and is qualified in its entirety by the full text of the Operating Agreement, a copy of which is attached as Exhibit 10.1 hereto. &#160;</P>
<P style='font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'>&#160;</P>
<P style='font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'><B>Item 8.01 Other Events</B></P>
<P style='font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'>&#160;</P>
<P style='font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'>On May 8, 2019, the Company issued a press release regarding the Joint Venture. A copy of the press release is attached hereto as Exhibit 99.1. Exhibit 99.1 shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities under that section and shall not be deemed to be incorporated into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act. &#160;</P>
<P style='font:10pt Times New Roman;margin:0;color:#000000'>&#160;</P>
<P style='font:10pt Times New Roman;margin:0;color:#000000'><B>Item 9.01. &#160;Financial Statements and Exhibits.</B></P>
<P style='font:10pt Times New Roman;margin:0;color:#000000'>&#160;</P>
<P style='font:10pt Times New Roman;margin:0;color:#000000'>(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits</P>
<P style='font:10pt Times New Roman;margin:0;margin-left:121.5pt;color:#000000'>&#160;</P>
<P style='font:10pt Times New Roman;margin:0;color:#000000'>The exhibits listed below are furnished as Exhibits to this Current Report on Form 8-K.</P>
<P style='font:10pt Times New Roman;margin:0;color:#000000'>&#160;</P>
<TABLE align=center style=border-collapse:collapse;width:469.5pt><TR style=height:10.8pt><TD valign=middle style=width:59.25pt;padding:0.75pt><P style='font:10pt Times New Roman;margin:0;color:#000000'>Exhibit No.</P>
</TD><TD valign=middle style=width:410.25pt;white-space:nowrap;padding:0.75pt><P style='font:10pt Times New Roman;margin:0;color:#000000'>Description</P>
</TD></TR>
<TR style=height:10.8pt><TD valign=middle style=width:59.25pt;padding:0.75pt><P style='font:10pt Times New Roman;margin:0;color:#000000'>10.1</P>
</TD><TD valign=middle style=width:410.25pt;white-space:nowrap;padding:0.75pt><P style='font:10pt Times New Roman;margin:0;color:#000000'><A href=nbgv_ex10z1.htm style=text-decoration:none><FONT style='color:#0000FF;border-bottom:1px solid #0000FF'>Operating Agreement dated May 2, 2019</FONT></A> </P>
</TD></TR>
<TR style=height:10.8pt><TD valign=middle style=width:59.25pt;padding:0.75pt><P style='font:10pt Times New Roman;margin:0;color:#000000'>99.1 </P>
</TD><TD valign=middle style=width:410.25pt;white-space:nowrap;padding:0.75pt><P style='font:10pt Times New Roman;margin:0;color:#000000'><A href=nbgv_ex99z1.htm style=text-decoration:none><FONT style='color:#0000FF;border-bottom:1px solid #0000FF'>Press Release regarding the Joint Venture dated May 8, 2019</FONT></A> </P>
</TD></TR>
<TR style=height:10.8pt><TD valign=middle style=width:59.25pt;padding:0.75pt><P style='font:10pt Times New Roman;margin:0;color:#000000'>&#160;</P>
</TD><TD valign=middle style=width:410.25pt;white-space:nowrap;padding:0.75pt><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0;margin-left:72pt;color:#000000'><FONT style=color:#4F81BD>&#160;</FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><B>SIGNATURES</B></P>
<P style='font:10pt Calibri;margin-top:0pt;margin-bottom:10pt'><FONT style='font-family:Times New Roman'>&#160;</FONT></P>
<P style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:10pt'>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</P>
<P style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:10pt'>&#160;</P>
<TABLE align=center style=border-collapse:collapse><TR><TD valign=top style=width:32.4pt;padding:0.75pt><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top style=width:207pt;padding:0.75pt><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD colspan=2 valign=top style=width:239.4pt;padding:0.75pt><P style='font:10pt Times New Roman;margin:0'><B>NewBridge Global Ventures, Inc.</B></P>
<P style='font:10pt Times New Roman;margin:0'>(Registrant)</P>
</TD></TR>
<TR><TD valign=top style=width:32.4pt;padding:0.75pt><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top style=width:207pt;padding:0.75pt><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top style=width:13.5pt;padding:0.75pt><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top style=width:225.9pt;padding:0.75pt><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD></TR>
<TR style=height:3.7pt><TD valign=top style=width:32.4pt;padding:0.75pt><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top style=width:207pt;padding:0.75pt><P style='font:10pt Times New Roman;margin:0'>Dated: May 8, 2019&#160;&#160;</P>
</TD><TD valign=top style=width:13.5pt;padding:0.75pt><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top style=width:225.9pt;padding:0.75pt><P style='font:10pt Times New Roman;margin:0'>By: &#160;&#160;&#160;&#160;/s/&#160;<I>Robert Bench</I></P>
<P style='font:10pt Times New Roman;margin:0'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name: &#160;&#160;Robert Bench</P>
<P style='font:10pt Times New Roman;margin:0'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title: &#160;&#160;&#160;&#160;Interim President and CFO</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:10pt'>&#160;&#160;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "nbgv_8k.htm", "description": "8-K", "secsgml_size_bytes": 13280}]
{"company-data": {"conformed-name": "NewBridge Global Ventures, Inc.", "cik": "0000726293", "assigned-sic": "0100", "irs-number": "841089377", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-11730", "film-number": "19808147"}, "business-address": {"street1": "2545 SANTA CLARA AVENUE", "city": "ALAMEDA", "state": "CA", "zip": "94501", "phone": "801-362-2115"}, "mail-address": {"street1": "2545 SANTA CLARA AVENUE", "city": "ALAMEDA", "state": "CA", "zip": "94501"}, "former-company": [{"former-conformed-name": "NABUfit Global, Inc.", "date-changed": "20160304"}, {"former-conformed-name": "CRYPTOSIGN, INC.", "date-changed": "20150930"}, {"former-conformed-name": "STRATEGABIZ, INC.", "date-changed": "20150210"}]}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 2, 2019
NEWBRIDGE GLOBAL VENTURES, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware
0-11730
84-1089377
(State or other jurisdiction
of incorporation)
Commission File
Number
(I.R.S. Employer Identification number)
2545 Santa Clara Avenue
Alameda, CA 94501
(Address of Principal Executive Offices)
801-362-2115
(Registrant's Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement
On May 2, 2019, NewBridge Global Ventures, Inc., a Delaware Corporation (the "Company") and Apothio, LLC, a Colorado limited liability company ("Apothio") entered into an Operating Agreement (the "Operating Agreement"), pursuant to which the Company and Apothio agreed to form Apothio Bakersefield, LLC, a Nevada limited liability company (the "Joint Venture"), whereby pursuant to the terms and subject to the conditions set forth in the Operating Agreement, the Company and Apothio shall each receive fifty percent (50%) of the membership interests in the Joint Venture. Under the terms of the Operating Agreement, the Company will be required to: (i) underwrite costs to contribute extraction equipment; (ii) fund the cost of a fully-functional extraction facility and (iii) install a fully-functional testing laboratory with certain equipment as determined by the managers of the Joint Venture. Apothio will contribute existing biomass of approximately 150,000 pounds for the Company to begin processing and extraction, and will contribute the use of its 512 acres of cannabinoids plants. The term of the Operating Agreement shall be perpetual absent certain dissolution provisions as further described in the Operating Agreement.
The Operating Agreement also provides for certain drag-along provisions, whereby the managers may require any members of the Joint Venture to sell their respective membership interests to a proposed purchaser.
The foregoing is merely a summary of the Operating Agreement, and is qualified in its entirety by the full text of the Operating Agreement, a copy of which is attached as Exhibit 10.1 hereto.
Item 8.01 Other Events
On May 8, 2019, the Company issued a press release regarding the Joint Venture. A copy of the press release is attached hereto as Exhibit 99.1. Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities under that section and shall not be deemed to be incorporated into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
Item 9.01.  Financial Statements and Exhibits.
(d)         Exhibits
The exhibits listed below are furnished as Exhibits to this Current Report on Form 8-K.
Exhibit No.
Description
10.1
Operating Agreement dated May 2, 2019
99.1
Press Release regarding the Joint Venture dated May 8, 2019
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
NewBridge Global Ventures, Inc.
(Registrant)
Dated: May 8, 2019
By:     /s/
Robert Bench
Name:   Robert Bench
Title:     Interim President and CFO